- Home
- STRO vs OUST Comparison
STRO vs OUST Comparison
Compare STRO & OUST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | STRO | OUST |
|---|---|---|
| Founded | 2003 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 332.8M | 2.9B |
| IPO Year | 2018 | 2020 |
Fundamental Metrics
Financial Performance| Metric | STRO | OUST |
|---|---|---|
| Price | $14.88 | $34.59 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 4 |
| Target Price | $31.33 | ★ $39.25 |
| AVG Volume (30 Days) | 253.7K | ★ 1.8M |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 48.56 |
| EPS | N/A | ★ N/A |
| Revenue | $38,419,000.00 | ★ $169,384,000.00 |
| Revenue This Year | N/A | $33.20 |
| Revenue Next Year | N/A | $37.27 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 52.46 |
| 52 Week Low | $0.72 | $16.40 |
| 52 Week High | $43.85 | $63.79 |
Technical Indicators
Market Signals| Indicator | STRO | OUST |
|---|---|---|
| Relative Strength Index (RSI) | 20.09 | 43.25 |
| Support Level | $12.85 | $33.03 |
| Resistance Level | $17.33 | $38.38 |
| Average True Range (ATR) | 1.08 | 1.60 |
| MACD | -0.31 | 0.03 |
| Stochastic Oscillator | 1.10 | 32.41 |
Price Performance
Historical ComparisonAbout STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About OUST Ouster Inc.
Ouster Inc is a provider of lidar sensors for the automotive, industrial, robotics, and smart infrastructure industries. Ouster's products include high-resolution scanning and solid-state digital lidar sensors, Velodyne Lidar sensors, and software solutions. The company operates in the Americas, Asia and the Pacific, Europe, the Middle East, and Africa. It derives maximum revenue from the Americas. The Company operates as one reportable and operating segment, which relates to the sale and production of lidar sensor kits.